Suppr超能文献

首次经蝶窦手术治疗生长激素、促肾上腺皮质激素和泌乳素分泌型垂体腺瘤后的内分泌学结果。

Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.

作者信息

Kristof R A, Schramm J, Redel L, Neuloh G, Wichers M, Klingmüller D

机构信息

Department of Neurosurgery, University of Bonn, Bonn, Germany.

出版信息

Acta Neurochir (Wien). 2002 Jun;144(6):555-61; discussion 561. doi: 10.1007/s00701-002-0938-1.

Abstract

BACKGROUND

To study remission rates and pituitary functions following transsphenoidal surgery of newly diagnosed GH-, ACTH-, and PRL-secreting pituitary adenomas.

METHODS

Out of a series of 329 newly diagnosed pituitary adenomas, 131 (39.8%) were hormone (67 GH-, 27 ACTH-, 37 PRL-) secreting. PRL-secreting adenomas were subjected to surgery because they failed to respond to previous medical treatment therapy. The data on secreting adenomas, regarding the results of standardised endocrinological testing, MRI findings and water metabolism disturbances, were extracted retrospectively from the pituitary data-base of the hospital. The mean follow-up was 3.7 years.

RESULTS

The overall remission rate for PRL-secreting adenomas (27%) was significantly lower than for GH- (71.6%) and ACTH-secreting (81.5%) ones. Remission rates correlated negatively with the magnitude of preoperative hormone excess (not in Cushing's disease), tumour size (not in prolactinoma) and invasiveness. Generally, the improvement of the adenopituitary functions was statistically significant during the first three postoperative months, and thereafter remained unchanged. Diabetes insipidus persisting for more than three months occurred with similar frequency in the three patient groups (in 9.4% of GH-, in 6.7% of ACTH-, and in 10% of PRL-secreting adenomas). Tumour regrowth occurred more often in PRL-(20%) than in ACTH- (9.1%) and GH- (0%) secreting tumours.

CONCLUSIONS

In GH- and ACTH-secreting pituitary adenomas, remission rates were significantly higher and recurrence rates lower than in PRL-secreting adenomas, which had failed to respond to previous medical therapy. The overall postoperative adenopituitary function was improved in all patient groups. Diabetes insipidus occurred with similar frequency in all patient groups. When reporting on results of surgery for secreting pituitary adenomas, not only remission and recurrence rates, but also the results of the pituitary function should be included.

摘要

背景

研究新诊断的生长激素(GH)、促肾上腺皮质激素(ACTH)和催乳素(PRL)分泌型垂体腺瘤经蝶窦手术后的缓解率及垂体功能。

方法

在329例新诊断的垂体腺瘤中,131例(39.8%)为激素分泌型(67例GH分泌型、27例ACTH分泌型、37例PRL分泌型)。PRL分泌型腺瘤因对先前的药物治疗无反应而接受手术。从医院垂体数据库中回顾性提取分泌型腺瘤的标准化内分泌检测结果、磁共振成像(MRI)表现及水代谢紊乱的数据。平均随访时间为3.7年。

结果

PRL分泌型腺瘤的总体缓解率(27%)显著低于GH分泌型(71.6%)和ACTH分泌型(81.5%)腺瘤。缓解率与术前激素过量程度(库欣病除外)、肿瘤大小(泌乳素瘤除外)及侵袭性呈负相关。一般来说,术后前三个月腺垂体功能改善具有统计学意义,此后保持不变。尿崩症持续超过三个月在三组患者中发生率相似(GH分泌型腺瘤患者中为9.4%,ACTH分泌型腺瘤患者中为6.7%,PRL分泌型腺瘤患者中为10%)。肿瘤复发在PRL分泌型肿瘤(20%)中比在ACTH分泌型肿瘤(9.1%)和GH分泌型肿瘤(0%)中更常见。

结论

在GH和ACTH分泌型垂体腺瘤中,缓解率显著高于对先前药物治疗无反应的PRL分泌型腺瘤,复发率则低于PRL分泌型腺瘤。所有患者组术后腺垂体功能总体均有改善。所有患者组尿崩症发生率相似。在报告分泌型垂体腺瘤手术结果时,不仅应包括缓解率和复发率,还应包括垂体功能结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验